Long-term stroke prevention: We can do better
- PMID: 28739846
- PMCID: PMC5524575
- DOI: 10.1503/cmaj.170410
Long-term stroke prevention: We can do better
Conflict of interest statement
Competing interests: Michael Hill reports personal fees from Merck, non-financial support from Hoffmann-La Roche Canada Ltd., and grants from Covidien (Medtronic Minimally Invasive Therapies), Boehringer Ingelheim, Medtronic, NoNO Inc. and Stryker Inc., outside the submitted work. In addition, he has a patent pending for systems and methods for assisting in decision-making and triaging for acute stroke patients to the US Patent Office, number 62/086,077. He owns stock in Calgary Scientific Inc., a company that focuses on medical imaging software; is a director of the Canadian Neurological Sciences Federation, a not-for-profit group; and has received grant support from Alberta Innovates: Health Solutions, the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada and the National Institutes of Neurological Disorders and Stroke.
Comment on
-
Long-term morbidity and mortality in patients without early complications after stroke or transient ischemic attack.CMAJ. 2017 Jul 24;189(29):E954-E961. doi: 10.1503/cmaj.161142. CMAJ. 2017. PMID: 28739847 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical